BioSpace News Archive

Microplate Washers Market to be Worth US$ 700 Mn by 2030, Increase in R&D Activities and Expenditure for New Products to Drive the Market

Albany NY, United States: According to the report, the global microplate washers market was valued at ~US$ 500 Mn in 2019.

April 21, 2022
·
6 min read
Platelet Agitators Market: Increasing prevalence of chronic diseases to drive the market

Albany NY, United States: Platelets are important factors of the blood. Their primary function is to prevent bleeding.

April 21, 2022
·
7 min read
Business

First-quarter results 2022 of Sartorius Stedim Biotech

Sartorius Stedim Biotech, a leading partner of the biopharma industry, recorded a dynamic start to fiscal 2022, with sales revenue and earnings posting strong double-digit growth rates in the first quarter compared with the prior-year period.

April 21, 2022
·
9 min read
Drug Development

Lysogene Publishes Positive Preliminary Preclinical Results in the Treatment of Fragile X Syndrome

Lysogene announced the publication of a peer-reviewed article in EMBO Molecular Medicine e14649) showing that adeno-associated viral vector-delivered diacylglycerol kinase achieves long-term rescue of fragile X syndrome in a mouse model of disease.

April 21, 2022
·
4 min read
Vicore launches COMPANION, a clinical study investigating the benefit of digital therapy on anxiety in patients with idiopathic pulmonary fibrosis (IPF)

Vicore Pharma Holding AB, a clinical-stage pharmaceutical company, announces the first patient enrolled in the pilot phase of COMPANION1, a clinical study of a digital cognitive behavioral therapy for patients with IPF.

April 21, 2022
·
4 min read
Business

DaVita Inc. Schedules 1st Quarter 2022 Investor Conference Call

DaVita Inc., announced that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m. Eastern Time.

April 21, 2022
·
1 min read
Business

Hansa Biopharma interim report January - March 2022

Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, announced its business update and interim report for January to March 2022.

April 21, 2022
·
9 min read
Biotech Bay

Boehringer Ingelheim launches RenuTend™: a new stem cell therapy to improve the healing of tendon and suspensory ligament injuries in horses

It takes years of diligent training as well as a trusting relationship between horse and rider to reach their full potential as a team.

April 21, 2022
·
2 min read
Oncopeptides publishes the 2021 Annual Report

Oncopeptides AB, a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, announces that the 2021 Annual Report has been published.

April 21, 2022
·
3 min read
Drug Development

Adiso Therapeutics Announces Completion of Enrollment in a Phase 1b Study of ADS024 for the Prevention of C. difficile Recurrence

Adiso Therapeutics, Inc. announced the completion of patient enrollment in the Phase 1b clinical study evaluating ADS024, an orally delivered single strain live biotherapeutic product, for the prevention of C. difficile infection recurrence.

April 21, 2022
·
4 min read